These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388 [TBL] [Abstract][Full Text] [Related]
5. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database. Pant C; Anderson MP; O'Connor JA; Marshall CM; Deshpande A; Sferra TJ Transpl Infect Dis; 2012 Oct; 14(5):540-7. PubMed ID: 22726461 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of Clostridium difficile infection in pediatric solid organ transplant recipients. Pant C; Deshpande A; Desai M; Jani BS; Sferra TJ; Gilroy R; Olyaee M Transpl Infect Dis; 2016 Feb; 18(1):31-6. PubMed ID: 26538348 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of C difficile infection in solid-organ transplant recipients: The National Inpatient Sample (NIS) 2015-2016. Mahatanan R; Tantisattamo E; Charoenpong P; Ferrey A Transpl Infect Dis; 2021 Feb; 23(1):e13459. PubMed ID: 32894617 [TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center. Tsapepas DS; Martin ST; Miao J; Shah SA; Scheffert J; Fester K; Ma K; Lat A; Egan R; McKeen JT Diagn Microbiol Infect Dis; 2015 Apr; 81(4):299-304. PubMed ID: 25586932 [TBL] [Abstract][Full Text] [Related]
9. The impact of Clostridioides difficile infection on outcomes among kidney transplant recipients. Iqbal H; Patel J; Singh I; Kohli I; Thind N; Dhiman M; Sohal A; Yang J Am J Infect Control; 2024 Jul; 52(7):795-800. PubMed ID: 38395312 [TBL] [Abstract][Full Text] [Related]
10. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients. Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852 [TBL] [Abstract][Full Text] [Related]
11. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice. Mullane KM; Dubberke ER; Clin Transplant; 2019 Sep; 33(9):e13564. PubMed ID: 31002420 [TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection in hospitalized children in the United States. Nylund CM; Goudie A; Garza JM; Fairbrother G; Cohen MB Arch Pediatr Adolesc Med; 2011 May; 165(5):451-7. PubMed ID: 21199971 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children. Ochfeld E; Balmert LC; Patel SJ; Muller WJ; Kociolek LK Transpl Infect Dis; 2019 Oct; 21(5):e13149. PubMed ID: 31332916 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients. Bruminhent J; Cawcutt KA; Thongprayoon C; Petterson TM; Kremers WK; Razonable RR Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28314071 [TBL] [Abstract][Full Text] [Related]
15. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients. Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662 [TBL] [Abstract][Full Text] [Related]
16. A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients. Alonso CD; Braun DA; Patel I; Akbari M; Oh DJ; Jun T; McMasters M; Hammond SP; Glotzbecker B; Cutler C; Leffler DA; Ballen KK; Kelly CP Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544102 [TBL] [Abstract][Full Text] [Related]
17. The Impact of Clostridium difficile Infection on Future Outcomes of Solid Organ Transplant Recipients. Luo R; Weinberg JM; Barlam TF Infect Control Hosp Epidemiol; 2018 May; 39(5):563-570. PubMed ID: 29553007 [TBL] [Abstract][Full Text] [Related]
18. An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization. Amjad W; Schiano T; Segovia MC; Malik A; Weiner J; Horslen S; Jafri SM Transpl Infect Dis; 2023 Feb; 25(1):e13951. PubMed ID: 36621893 [TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care. Olanipekun TO; Salemi JL; Mejia de Grubb MC; Gonzalez SJ; Zoorob RJ Diabetes Res Clin Pract; 2016 Jun; 116():68-79. PubMed ID: 27321318 [TBL] [Abstract][Full Text] [Related]
20. Reduced Clostridioides difficile Tests Among Solid Organ Transplant Recipients Through a Diagnostic Stewardship Bundled Intervention. Madden GR; Sifri CD Ann Transplant; 2019 May; 24():304-311. PubMed ID: 31133632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]